Open App
Company / Corporate

Rain.

Follow Rain

Rain Oncology Inc. is a precision oncology company developing therapies that target oncogenic drivers to genetically select patients it believes will most likely benefit.[1]

01Deal
01

Deals on Carrywatch

Every deal that names Rain, and its role in each.

Pathos / Rain

Pathos AI completes acquisition of Rain Oncology

See deal details
02

Deal Web

Rain and 0 firms it shares a posted deal with, and the path to any other firm.

03

News

Loading headlines.

04

Sources

As of 24 Oct 2026.

  1. 01
    PATHOS AI COMPLETES ACQUISITION OF RAIN ONCOLOGY

    U.S. Securities and Exchange Commission · Researched 24 Oct 2026

  2. 02
    AMENDMENT TO FORM SC TO-T

    U.S. Securities and Exchange Commission · Researched 24 Oct 2026

Deal posts naming Rain:

  1. P01